Evidence map›Paper›PMID 31583069›Full record

ArticleChemical science2019

Total synthesis of griseusins and elucidation of the griseusin mechanism of action.

Yinan Zhang, Qing Ye, Larissa V Ponomareva, Yanan Cao, Yang Liu, Zheng Cui, Steven G Van Lanen, S Randal Voss, Qing-Bai She, Jon S Thorson

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. An overview of structure-based activity outcomes of pyran derivatives against Alzheimer's disease.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  5. Activation and Identification of a Griseusin Cluster inMolecules (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. OleD Loki as a Catalyst for Hydroxamate Glycosylation.Chembiochem : a European journal of chemical biology · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Yinan ZhangJiangsu Key Laboratory for Functional Substances of Chinese Medicine , School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , Jiangsu 210023 , China.ORCID 0000-0002-0362-1473
Qing YeMarkey Cancer Center , Department of Pharmacology and Nutritional Sciences , College of Medicine , University of Kentucky , Lexington , KY 40536 , USA . Email: qing-bai.she@uky.edu.
Larissa V PonomarevaCenter for Pharmaceutical Research and Innovation , University of Kentucky , Lexington , KY 40536 , USA.
Yanan CaoMarkey Cancer Center , Department of Pharmacology and Nutritional Sciences , College of Medicine , University of Kentucky , Lexington , KY 40536 , USA . Email: qing-bai.she@uky.edu.
Yang LiuCenter for Pharmaceutical Research and Innovation , University of Kentucky , Lexington , KY 40536 , USA.
Zheng CuiCollege of Pharmacy , University of Kentucky , Lexington , KY 40536 , USA . Email: jsthorson@uky.edu.
Steven G Van LanenCollege of Pharmacy , University of Kentucky , Lexington , KY 40536 , USA . Email: jsthorson@uky.edu.
S Randal VossDepartment of Neuroscience , Spinal Cord and Brain Injury Research Center , Ambystoma Genetic Stock Center , University of Kentucky , Lexington , KY 40536 , USA.
Qing-Bai SheMarkey Cancer Center , Department of Pharmacology and Nutritional Sciences , College of Medicine , University of Kentucky , Lexington , KY 40536 , USA . Email: qing-bai.she@uky.edu.ORCID 0000-0002-7207-0599
Jon S ThorsonCenter for Pharmaceutical Research and Innovation , University of Kentucky , Lexington , KY 40536 , USA.ORCID 0000-0002-7148-0721
University of Kentucky · USNanjing University of Chinese Medicine · CN

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
Targeting Translation Dependence in Colorectal Cancer ProgressionR01CA175105 · NCI · UNIVERSITY OF KENTUCKY · PI SHE, QING-BAI · 2013 to 2024
$3.3M
Developing Regeneration Resources for a Model AmphibianR24OD021479 · OD · UNIVERSITY OF KENTUCKY · PI THORSON, JON SCOTT, VOSS, STEPHEN RANDAL · 2016 to 2019
$2.3M
Natural product-based modulators of 4E-BP1 phosphorylationR01CA203257 · NCI · UNIVERSITY OF KENTUCKY · PI SHE, QING-BAI, THORSON, JON SCOTT · 2016 to 2020
$1.9M
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NCI NIH HHS R01 CA175105NCI NIH HHS R01 CA203257NIDA NIH HHS T32 DA016176NIH HHS R24 OD021479
6 · The paper itself

Abstract

A divergent modular strategy for the enantioselective total synthesis of 12 naturally-occurring griseusin type pyranonaphthoquinones and 8 structurally-similar analogues is described. Key synthetic highlights include Cu-catalyzed enantioselective boration-hydroxylation and hydroxyl-directed C-H olefination to afford the central pharmacophore followed by epoxidation-cyclization and maturation

Identifiers

PMID31583069
PMCPMC6755659
OpenAlexW2955413328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.